The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, March 2024
|
DOI | 10.1186/s40545-023-00570-z |
Pubmed ID | |
Authors |
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini, Claudio Jommi |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 5% |
Student > Doctoral Student | 1 | 5% |
Student > Bachelor | 1 | 5% |
Student > Master | 1 | 5% |
Researcher | 1 | 5% |
Other | 1 | 5% |
Unknown | 15 | 71% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 14% |
Arts and Humanities | 1 | 5% |
Unspecified | 1 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Unknown | 15 | 71% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2024.
All research outputs
#15,708,190
of 26,181,776 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#306
of 539 outputs
Outputs of similar age
#144,275
of 349,735 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#39
of 97 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 539 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,735 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.